Ursprung des Netzwerks ersten Grades von Joyce James
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Lyric Pharmaceuticals, Inc.
 Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA.
3
| Private Company | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Joyce James
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal | |
Epoch Biosciences, Inc.
 Epoch Biosciences, Inc. Medical SpecialtiesHealth Technology Epoch Biosciences, Inc. manufactures and develops molecular tools for genetic analysis. Its technology has numerous applications including the detection of inherited diseases and single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions and gene expression measurement. The company was founded in 1985 and is headquartered in Bothell, WA. | Medical Specialties | President | |
| COMPUGEN LTD. | Biotechnology | Director/Board Member | |
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ANTHERA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| REALM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Avaxia Biologics, Inc.
 Avaxia Biologics, Inc. BiotechnologyHealth Technology Avaxia Biologics, Inc. operated as a clinical-stage biotechnology company. It engaged in the development of gut-targeted antibody therapeutics for gastroenterology indications. Gut-targeted antibody therapeutics is orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal (GI) tract including the mouth, throat, and intestines. The company was founded by David Poorvin and Barbara S. Fox in 2005 and was headquartered in Lexington, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| PAVMED INC. | Medical Specialties | Chief Operating Officer | |
| George Washington University | College/University | Graduate Degree | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of California, Davis | College/University | Graduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Director of Finance/CFO | |
Reedland Capital Partner
 Reedland Capital Partner Investment ManagersFinance Part of Paradox Holdings, Inc., Reedland Capital Partner provides investment advice. The company is based in Mill Valley, CA. The CEO of the company is Robert Schachter. | Investment Managers | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree | |
| Tranzyme Pharma, Inc. (Canada) | Chief Tech/Sci/R&D Officer | ||
| ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| Middleburg Consultants, Inc. | Corporate Officer/Principal | ||
| Georgetown University School of Medicine | College/University | Corporate Officer/Principal | |
| University of Wisconsin School of Medicine & Public Health | College/University | Graduate Degree | |
Nuvelution Pharma, Inc.
 Nuvelution Pharma, Inc. BiotechnologyHealth Technology Nuvelution Pharma, Inc. provides solutions for R&D companies in the pharmaceutical and biotech industries. The firm leverages its knowledge, experience and relationships in the Pharma and Biotech industries to deploy capital in risk-sharing collaborations with companies where product development can be facilitated by both capital and human resources, making this model an essential tool for pharma and biotech companies to bring products to the market. The company was founded by Sanford S. Zweifach and is headquartered in South San Francisco, CA. | Biotechnology | Founder | |
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
Janpix Holdings, Inc.
 Janpix Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Janpix Holdings, Inc. engages in provision of research and experimental development on biotechnology. The company was founded by Patrick T. Gunning and Cortes Pierre and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman | |
| ALTIMMUNE, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman | |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Director/Board Member | |
Imidomics, Inc.
 Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Biotechnology | Corporate Officer/Principal | |
Pathway Diagnostics Ltd.
 Pathway Diagnostics Ltd. Medical DistributorsDistribution Services Pathway Diagnostics Ltd. provides clinical diagnostic products and medical instrumentation services. Its products include haemostasis, autoimmune and allergy, complement system, bone and cartilage, metabolic syndrome, organ injury, oncology and toxicology. The company was founded in 1999 and is headquartered in Dorking, the United Kingdom. | Medical Distributors | Chief Executive Officer | |
| LUCID DIAGNOSTICS INC. | Medical Specialties | Chief Operating Officer | |
| Kaerus Bioscience Ltd. | Chairman | ||
| Syndexis SARL | Director/Board Member | ||
| WEST VIRGINIA HEALTH IMPROVEMENT INSTITUTE, INC. | Corporate Officer/Principal | ||
| CARISMA THERAPEUTICS, INC. | Biotechnology | Chairman |
Statistik
International
| Vereinigte Staaten | 28 |
| Kanada | 4 |
| Vereinigtes Königreich | 4 |
| Israel | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 20 |
| Consumer Services | 7 |
| Finance | 4 |
| Commercial Services | 2 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 10 |
| Corporate Officer/Principal | 7 |
| Chief Tech/Sci/R&D Officer | 6 |
| Chairman | 5 |
| Independent Dir/Board Member | 5 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Sanford Zweifach | 22 |
| M. Harris | 10 |
| Randy Brown | 6 |
- Börse
- Insiders
- Joyce James
- Unternehmensverbindungen
